Summary
The tricyclic compound cyproheptadine (Periactinol®, Nuran®) inhibited glucose-induced insulin release from the perfused rat pancreas. Tolbutamide-stimulated insulin release was significantly reduced in the presence and completely suppressed in the absence of a substimulatory glucose concentration (5 mM). Arginine produced a slow rise of insulin release, which was completely abolished by cyproheptadine. Furthermore the biphasic glucagon release due to the stimulus was inhibited. Oxidation of 14C-glucose in isolated islets was unaltered in the presence of cyproheptadine, and pyruvate added to the perfusion medium failed to reverse the inhibitory effect on glucose induced insulin release, indicating that impaired glucose metabolism is not responsible for the inhibition. In addition, the inhibition remained unchanged when phentolamine was present, suggesting that the effect is not mediated by inhibitory adrenergic alpha receptors. Theophylline, in contrast, partly overcame the inhibition. When the calcium concentration of the medium was enhanced, the inhibitory effect of cyproheptadine was still visible, although the relative inhibition had become smaller. The results suggest that cyproheptadine blocks insulin release by affecting a fundamental step of the stimulus-secretion coupling common to peptide hormones. A participation of a calcium-antagonizing effect in the inhibition is discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Stone, C. A., Wenger, H. C., Ludden, C. T., Stavorski, J. M., Ross, C. A.: Antiserotonin-antihistaminic properties of cyproheptadine. J. Pharmacol. exp. Ther. 131, 73–84 (1961)
Longnecker, D. S., Wold, J. S., Fischer, L. J.: Ultrastructural alterations in B-cells of pancreatic islets from cyproheptadine treated rats. Diabetes 21, 71–79 (1972)
Wold, J. S., Longnecker, D. S., Fischer, L. J.: Species dependent pancreatic islet toxicity produced by cyproheptadine: Alteration in beta cell structure and function. Toxicol. appl. Pharmacol. 19, 188–201 (1971)
Rickert, D. E., Burke, J., Fischer, L. J.: Cyproheptadine-induced depletion of insulin in the rat. J. Pharmacol. exp. Ther. 193, 585–593 (1975)
Joost, H. G., Poser, W., Panten, U.: Inhibition of insulin release from the rat pancreas by cyproheptadine and tricyclic antidepressants. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, 99–102 (1974)
Feldman, J. M., Chapman, B. A., Plonk, J. W.: Monoamine oxidase inhibition: Possible mechanism for cyproheptadine-induced alterations in insulin secretion. Life Sci. 15, 1121–1134 (1974)
Joost, H. G., Beckmann, J.: Inhibition of insulin release by cyproheptadine in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, R 59 (1975)
Richardson, B. P., McDaniel, M. L., Lacy, P. E.: Effects of cyproheptadine on insulin secretion by isolated perifused rat islets. Diabetes 24, 836–841 (1975)
Bivens, C. H., Lebovitz, H. E., Feldman, J. M.: Inhibition of hypoglycemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide. New Engl. J. Med. 289, 236–239 (1973)
Nakai, Y., Imura, H., Sakurai, H., Kurahachi, H., Yoshimi, T.: Effect of cyproheptadine on human growth hormone secretion. J. clin. Endocr. 38, 446–449 (1974)
Plonk, J. W., Bivens, C. H., Feldman, J. M.: Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadine. J. clin. Endocr. 38, 836–840 (1974)
Grodsky, G. M., Batts, A. A., Bennett, L. L., Vcella, C., McWilliams, N. B., Smith, D. F.: Effects of carbohydrates on secretion of insulin from isolated rat pancreas. Amer. J. Physiol. 205, 638–644 (1963)
Klöppel, G.: Personal communication
Ashcroft, J. H., Hedeskov, C. J., Randle, P. J.: Glucose metabolism in mouse pancreatic islets. Biochem. J. 118, 143–154 (1970)
Zaharko, D. S., Beck, L. V.: Studies of a simplified plasma insulin immunoassay using cellulose powder. Diabetes 17, 444–457 (1968)
Frohman, L. A., Reichlin, M., Sokal, J. E.: Immunologic and biologic properties of antibodies to a glucagon-serum albumin polymer. Endocrinology 87, 1055–1061 (1970)
Gerich, J. E., Charles, M. A., Grodsky, G. M.: Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J. clin. Invest. 54, 833–841 (1974)
Rickert, D. E., Fischer, L. J.: Cyproheptadine and betacellfunction in the rat: Insulin secretion from pancreas segments in vitro. Proc. Soc. exp. Biol. (N. Y.) 150, 1–6 (1975)
Lernmark, A.: The significance of 5-hydroxytryptamine for insulin secretion in the mouse. Horm. Metab. Res. 3, 305–309 (1971)
Matschinsky, F. M., Ellerman, J.: Dissociation of the insulin releasing and the metabolic functions of hexoses in islets of Langerhans. Biochem. biophys. Res. Commun. 50, 193–199 (1973)
Lenzen, S., Panten, U., Hasselblatt, A.: Thyroxine treatment and insulin secretion in the rat. Diabetologia 11, 49–55 (1975)
Hellman, B., Idahl, L. A., Lernmark, A., Täljedal, I. B.: The pancreatic β-cell recognition of insulin secretagogues: Does cyclic AMP mediate the effect of glucose? Proc. nat. Acad. Sci. (Wash.) 71, 3405–3409 (1974)
Cooper, R. H., Ashcroft, S. J. H., Randle, P. J.: Concentration of adenosine-3′5′-cyclic monophosphate in mouse pancreatic islets measured by a protein-binding radioassay. Biochem. J. 134, 599–605 (1973)
Kuo, W. N., Hodkins, D. S., Kuo, J. F.: Regulation by various hormones and agents of adenosine-3′, 5′-monophosphate levels of islets of Langerhans in rats. Biochem. Pharmacol. 23, 1387–1391 (1974)
Brisson, G. R., Malaisse-Lagae, F., Malaisse, W. J.: The stimulus-secretion coupling of glucose-induced insulin release. VII. A proposed site of action for adenosine-3′, 5′-cyclicmonophosphate. J. clin. Invest. 51, 232–241 (1972)
Charles, M. A., Lawecki, J., Pictet, R., Grodsky, G. M.: Insulin secretion. Interrelationships of glucose, cyclic adenosine 3′–5′-monophosphate, and calcium. J. biol. Chem. 250, 6134–6140 (1975)
Curry, D. L., Bennett, L. L., Grodsky, G. M.: Requirement for calcium ion in insulin secretion by the perfused rat pancreas. Amer. J. Physiol. 214, 174–178 (1968)
Malaisse, W. J., Pipeleers, D. G., Mahy, M.: The stimulus-secretion coupling of glucose-induced insulin release XII. Effects of diazoxide and gliclazide upon 45calcium efflux from perifused islets. Diabetologia 9, 1–5 (1973)
Matthews, E. K., Evans, R. J., Dean, P. M.: The ionogenic nature of the secretory-granule membrane. Biochem. J. 130, 825–832 (1972)
Joost, H. G., Beckmann, J., Lenzen, S., Hasselblatt, A.: Inhibition of insulin release by cyproheptadine: Effects on 3′, 5′-cyclic-AMP-content and 45Ca-accumulation of incubated mouse islets. Acta endocr. (Kbh.). (in press 1976)
Hellman, B.: The significance of calcium for glucose stimulation of insulin release. Endocrinology 97, 392–398 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Joost, H.G., Beckmann, J., Holze, S. et al. Inhibition of insulin and glucagon release from the perfused rat pancreas by cyproheptadine (Periactinol®, Nuran®). Diabetologia 12, 201–206 (1976). https://doi.org/10.1007/BF00422086
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00422086